Ocakli Birsen, Acarturk Eylem, Aksoy Emine, Gungor Sinem, Ciyiltepe Fulya, Oztas Selahattin, Ozmen Ipek, Agca Meltem Coban, Salturk Cuneyt, Adiguzel Nalan, Karakurt Zuhal
Department of Chest Diseases, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.
Int J Chron Obstruct Pulmon Dis. 2018 Apr 18;13:1261-1267. doi: 10.2147/COPD.S162658. eCollection 2018.
The aim of this study was to evaluate the impact of exposure to biomass smoke vs cigarette smoke on serum inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure (CRF).
A total of 106 patients with CRF divided into age and gender-matched groups of cigarette-smoke exposure (n=55, mean [SD] age: 71.0 [12.0] years, 92.7% were females) and biomass smoke exposure (n=51, mean [SD] age: 73.0 [11.0] years, 94.1% were females) were included in this retrospective study. Data on patient demographics (age and gender), inflammatory markers, including neutrophil-to-lymphocyte ratio, C-reactive protein, platelet/mean platelet volume ratio, arterial blood gas analysis, and pulmonary function test findings, including forced expiratory volume in 1 second (FEV), forced vital capacity (FVC), and FEV/FVC were obtained from medical records.
Carbon dioxide partial pressure levels were significantly higher in the biomass smoke exposure than in the cigarette smoke exposure group (mean [SD] 51.0 [8.0] vs 47.0 [8.0] mmHg, =0.026, respectively). Spirometry revealed similarly low levels for FEV (%) (38.0 [16.0] vs 40.0 [12.0]%) and FVC (%) (45.0 [19.0] vs 39.0 [19.0]%) in cigarette-smoke and biomass smoke exposure groups, whereas biomass smoke exposure was associated with significantly higher FEV/FVC (75.0 [14.0] vs 58.0 [12.0]%, =0.001), lower FVC (mL) (mean [SD] 744.0 [410.0] vs 1,063.0 [592.0] mL, =0.035) and lower percentage of patients with FEV/FVC <70% (36.8% vs 82.0%, <0.001) than cigarette smoke exposure.
Our findings indicate similarly increased inflammatory markers and abnormally low pulmonary function test findings in both biomass smoke exposure and cigarette smoke exposure groups, emphasizing the adverse effects of biomass smoke exposure on lungs to be as significant as cigarette smoke exposure. Association of biomass smoke exposure with higher likelihood of FEV/FVC ratio of >70% and more prominent loss of vital capacity than cigarette smoke exposure seems to indicate the likelihood of at least 18 years of biomass exposure to be sufficiently high to be responsible for both obstructive and restrictive pulmonary diseases.
本研究旨在评估接触生物质烟雾与接触香烟烟雾对慢性呼吸衰竭(CRF)患者血清炎症标志物和肺功能参数的影响。
本回顾性研究共纳入106例CRF患者,分为年龄和性别匹配的接触香烟烟雾组(n = 55,平均[标准差]年龄:71.0[12.0]岁,92.7%为女性)和接触生物质烟雾组(n = 51,平均[标准差]年龄:73.0[11.0]岁,94.1%为女性)。从病历中获取患者人口统计学数据(年龄和性别)、炎症标志物,包括中性粒细胞与淋巴细胞比值、C反应蛋白、血小板/平均血小板体积比、动脉血气分析以及肺功能测试结果,包括1秒用力呼气量(FEV)、用力肺活量(FVC)和FEV/FVC。
接触生物质烟雾组的二氧化碳分压水平显著高于接触香烟烟雾组(平均[标准差]分别为51.0[8.0]和47.0[8.0]mmHg,P = 0.026)。肺量计显示,接触香烟烟雾组和接触生物质烟雾组的FEV(%)(38.0[16.0]对40.0[12.0]%)和FVC(%)(45.0[19.0]对39.0[19.0]%)水平同样较低,而接触生物质烟雾与显著更高的FEV/FVC(75.0[14.0]对58.0[12.0]%,P = 0.001)、更低的FVC(mL)(平均[标准差]744.0[410.0]对1063.0[592.0]mL,P = 0.035)以及FEV/FVC<70%的患者比例更低(36.8%对82.0%,P<0.001)相关,高于接触香烟烟雾组。
我们的研究结果表明,接触生物质烟雾组和接触香烟烟雾组的炎症标志物均同样升高,肺功能测试结果异常低,强调接触生物质烟雾对肺部的不良影响与接触香烟烟雾一样显著。接触生物质烟雾与FEV/FVC比值>70%的可能性更高以及比接触香烟烟雾更明显的肺活量丧失相关,这似乎表明至少18年的生物质接触可能性足够高,足以导致阻塞性和限制性肺部疾病。